511 related articles for article (PubMed ID: 1653111)
21. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
22. Effects of dicentrine, a novel alpha 1-adrenoceptor antagonist, on human hyperplastic prostates.
Yu SM; Ko FN; Chueh SC; Chen J; Chen SC; Chen CC; Teng CM
Eur J Pharmacol; 1994 Jan; 252(1):29-34. PubMed ID: 7512043
[TBL] [Abstract][Full Text] [Related]
23. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
Shi AG; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1989 Sep; 250(3):1119-24. PubMed ID: 2550616
[TBL] [Abstract][Full Text] [Related]
24. Alpha-adrenergic vasoconstriction and receptor subtypes in large coronary arteries of calves.
Young MA; Vatner DE; Knight DR; Graham RM; Homcy CJ; Vatner SF
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1452-9. PubMed ID: 2904772
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery.
Abel PW; Minneman KP
J Pharmacol Exp Ther; 1986 Dec; 239(3):678-86. PubMed ID: 2879031
[TBL] [Abstract][Full Text] [Related]
26. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
27. Alpha-adrenoceptors in dog mesenteric vessels--subcellular distribution and number of [3H]prazosin and [3H]rauwolscine binding sites.
Shi AG; Ahmad S; Kwan CY; Daniel EE
J Cardiovasc Pharmacol; 1990 Apr; 15(4):515-26. PubMed ID: 1691379
[TBL] [Abstract][Full Text] [Related]
28. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
29. Characterization of alpha adrenoceptors in pial arteries of the bovine brain.
Tsukahara T; Taniguchi T; Fujiwara M; Handa H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):88-93. PubMed ID: 6316168
[TBL] [Abstract][Full Text] [Related]
30. Responses to noradrenaline in human subcutaneous resistance arteries are mediated by both alpha 1- and alpha 2-adrenoceptors.
Nielsen H; Mortensen FV; Mulvany MJ
Br J Pharmacol; 1990 Jan; 99(1):31-4. PubMed ID: 1970494
[TBL] [Abstract][Full Text] [Related]
31. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
Bobik A
Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
[TBL] [Abstract][Full Text] [Related]
32. Specific binding of [3H]prazosin to myocardial cells isolated from adult rats.
Skomedal T; Aass H; Osnes JB
Biochem Pharmacol; 1984 Jun; 33(12):1897-906. PubMed ID: 6329225
[TBL] [Abstract][Full Text] [Related]
33. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan.
Reader TA; Brière R; Grondin L
J Neural Transm; 1987; 68(1-2):79-95. PubMed ID: 2879884
[TBL] [Abstract][Full Text] [Related]
34. Differences in alpha-adrenergic responsiveness between human internal mammary arteries and saphenous veins.
Weinstein JS; Grossman W; Weintraub RM; Thurer RL; Johnson RG; Morgan KG
Circulation; 1989 Jun; 79(6):1264-70. PubMed ID: 2566395
[TBL] [Abstract][Full Text] [Related]
35. Binding of [3H]prazosin and [3H]p-aminoclonidine to alpha-adrenoceptors in rat spinal cord.
Simmons RM; Jones DJ
Brain Res; 1988 Apr; 445(2):338-49. PubMed ID: 2836025
[TBL] [Abstract][Full Text] [Related]
36. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
Reynen PH; Martin GR; Eglen RM; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(7):1339-46. PubMed ID: 10742289
[TBL] [Abstract][Full Text] [Related]
37. Characterization of alpha-adrenoceptor subtypes by [3H]prazosin and [3H]rauwolscine binding to canine venous smooth muscle membranes.
Shi AG; Ahmad S; Kwan CY; Daniel EE
Can J Physiol Pharmacol; 1989 Sep; 67(9):1067-73. PubMed ID: 2557148
[TBL] [Abstract][Full Text] [Related]
38. The bindings of 3H-prazosin and 3H-yohimbine to alpha adrenoceptors in the guinea-pig stomach.
Taniguchi T; Nishikawa H; Yokotani K; Fujiwara M
Life Sci; 1988; 42(23):2341-7. PubMed ID: 2836683
[TBL] [Abstract][Full Text] [Related]
39. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human alpha 2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands.
Halme M; Sjöholm B; Savola JM; Scheinin M
Biochim Biophys Acta; 1995 Apr; 1266(2):207-14. PubMed ID: 7742388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
